Marc Cantillon
2021
In 2021, Marc Cantillon earned a total compensation of $502K as Former Chief Medical Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 990% increase compared to previous year.
Compensation breakdown
| Bonus | $116,981 |
|---|---|
| Salary | $385,000 |
| Total | $501,981 |
Cantillon received $385K in salary, accounting for 77% of the total pay in 2021.
Cantillon also received $117K in bonus.
Rankings
In 2021, Marc Cantillon's compensation ranked 10,716th out of 12,415 executives tracked by ExecPay. In other words, Cantillon earned more than 13.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,716 out of 12,415 | 14th |
Division Manufacturing | 4,726 out of 5,505 | 14th |
Major group Chemicals And Allied Products | 2,122 out of 2,375 | 11th |
Industry group Drugs | 1,885 out of 2,096 | 10th |
Industry Pharmaceutical Preparations | 1,397 out of 1,546 | 10th |
Source: SEC filing on October 11, 2022.
Cantillon's colleagues
We found two more compensation records of executives who worked with Marc Cantillon at REVIVA PHARMACEUTICALS HOLDINGS in 2021.